Developing Blood Based Biomarkers For Stroke

Steffen Tiedt, PhD, Institute for

Maria Alonso De Leciñana, MD, PhD, La Paz University Hospital, Madrid, Spain, discusses the potential of

Mira Katan, MD, MSc, FESO, University Hospital and University of Basel, Basel, Switzerland, discusses various

Like many neurological diseases, signs and symptoms of

Maria Alonso De Leciñana, MD, PhD, La Paz University Hospital, Madrid, Spain, discusses the potential application of ...

Maria Alonso De Leciñana, MD, PhD, La Paz University Hospital, Madrid, Spain, comments on the potential of

Mira Katan, MD, MSc, FESO, University Hospital of Zurich, Zurich, Switzerland, discusses the use of

Roy H Behnke MD Grand Rounds William Scott Burgin MD.

Neurofilament light chain (NfL) has been identified as a sensitive but non-specific

Ana Catarina Fonseca, MD, PhD, University of Lisbon, Lisbon, Portugal, discusses recent updates on

Louis Caplan, MD, Harvard Medical School, Boston, MA, talks about how

Ke Jian (Jim) Liu, Ph.D., Professor, Pharmaceutical Sciences at the University of New Mexico describes his technology "

Mira Katan, MD, MSc, FESO, University Hospital and University of Basel, Basel, Switzerland, talks on the use of

Presentation Title:

From Discovery to Impact: What's Next for Epigenomics and

In honor of Autism Awareness Month, we had the privilege to interview Dr. Michael Breen. We asked him about the role of

Cerebral amyloid angiopathy (CAA) is a common small vessel disease (SVD) particularly associated with hemorrhagic

Interview Jeff June, Ischemia Care. Developed molecular diagnostic for cause of

PA Jordan Mast explains how

7th Munich Metabolomics Symposium 14.11.2020 Dr. Steffen Tiedt LMU Munich List of Speakers and titles in this playlist (Day 2): ...